Diethylene Glycol contamination
Investigation Reveals Safety Lapses and Regulatory Failures in Fatal Cough Syrup Contamination Case
Nov 21, 2025 04:14 pm CST
An exclusive investigation into the deaths of 24 children from contaminated cough syrup has uncovered serious safety breaches in India's pharmaceutical supply chain. The report details how improper handling of propylene glycol solvent, unauthorized repackaging by unlicensed distributors, and inadequate regulatory oversight may have allowed toxic diethylene glycol to contaminate Coldrif cough syrup, raising new concerns about quality control in India's $50 billion pharmaceutical industry.
WHO Issues Urgent Global Alert: Toxic Cough Syrups Linked to Child Deaths in India
Oct 14, 2025 01:49 pm CST
The WHO has issued a global health alert against three contaminated cough syrups from India - Coldrif, Respifresh TR, and ReLife - after 25 children died. The products contain toxic Diethylene Glycol and pose life-threatening risks. Authorities have halted production and initiated recalls while warning healthcare professionals worldwide to report any detections of these dangerous medicines.
Tamil Nadu Authorities Revoke License of Pharmaceutical Firm Linked to Fatal Cough Syrup Cases
Oct 14, 2025 12:31 am CST
The Tamil Nadu Drug Control department has revoked Sresan Pharmaceuticals' manufacturing license following the discovery of over 350 serious violations at their facility. Their 'Coldrif' cough syrup, contaminated with diethylene glycol, caused multiple child deaths in Madhya Pradesh and Rajasthan. The Enforcement Directorate has launched raids at seven Chennai locations as investigations expand into potential financial irregularities related to the distribution of the toxic medication.
ED Raids Premises of Pharmaceutical Firm Linked to Fatal Cough Syrup: 20 Children Dead from Contaminated Medication
Oct 13, 2025 12:14 pm CST
The Enforcement Directorate has raided multiple premises of Sresan Pharmaceuticals, manufacturer of 'Coldrif' cough syrup that contained toxic diethylene glycol and caused at least 20 children's deaths. The investigation revealed over 350 violations at the company's facility, prompting state bans and WHO concerns about India's regulatory gaps in drug safety screening.
Deadly Cough Syrup Tragedy: How Tamil Nadu Regulatory Failures Led to 23 Children's Deaths
Oct 11, 2025 02:32 pm CST
An investigation by India's Central Drugs Standard Control Organisation reveals critical regulatory failures by Tamil Nadu authorities that allowed a pharmaceutical company to produce toxic cough syrup containing 48% diethylene glycol, resulting in the deaths of 23 children in Madhya Pradesh. The manufacturer operated for decades without proper certification, audits, or registration on mandatory regulatory portals.
WHO Warns of Regulatory Gaps After Fatal Cough Syrup Contamination in India
Oct 09, 2025 01:10 pm CST
The World Health Organization has raised concerns about India's regulatory gaps in screening for toxic chemicals in medicines after contaminated cough syrups caused the deaths of 20 children in Madhya Pradesh and Rajasthan. WHO highlighted the potential international risk of such products being exported through unregulated channels, following the discovery of high levels of diethylene glycol in several cough syrup brands.
India's Drug Regulator Acknowledges Pharmaceutical Manufacturing Lapses Following Fatal Cough Syrup Incidents
Oct 09, 2025 12:51 am CST
India's top drug regulator has admitted serious deficiencies in pharmaceutical manufacturing practices after children died from suspected contaminated cough syrups. CDSCO investigations revealed manufacturers failing to test raw materials and finished products as required by law, leading to stricter enforcement measures nationwide. The scandal has damaged India's reputation as a global pharmaceutical supplier, with multiple states implementing emergency restrictions on cough medication distribution.
India's Drug Regulator Issues Critical Advisory Following Fatal Cough Syrup Contamination Cases
Oct 09, 2025 12:51 am CST
India's drug regulator has issued an urgent advisory highlighting serious lapses in pharmaceutical manufacturing practices after multiple child deaths linked to contaminated cough syrups. Inspections revealed manufacturers failing to test raw materials and finished products as required by law, prompting increased regulatory scrutiny across states and renewed concerns about India's pharmaceutical quality control systems.
Kerala Bans Coldrif Cough Syrup Following Child Fatalities in Multiple States
Oct 05, 2025 12:20 am CST
Kerala has joined Tamil Nadu and Madhya Pradesh in banning Coldrif cough syrup after 11 children died across multiple states. Manufactured by Sresan Pharma, the medication is under investigation for potential Diethylene Glycol contamination. Health authorities have sealed the manufacturing facility, collected samples for testing, and initiated nationwide inspections of pharmaceutical plants to prevent further incidents and ensure medication safety standards.
Deadly Contamination: Madhya Pradesh Bans Coldrif Cough Syrup After 10 Deaths and Confirmed Diethylene Glycol Presence
Oct 04, 2025 05:16 pm CST
The Madhya Pradesh government has banned 'Coldrif' cough syrup after an NDTV report revealed it contained 48.6% Diethylene Glycol, a toxic industrial solvent. Ten deaths have been linked to the medication, with affected children showing symptoms consistent with DEG poisoning. All products from manufacturer Sresan Pharmaceuticals have been suspended pending investigation.